Heavy Metals as Accelerators of Dementia Progression: Evidence From a Stage-Specific Systematic Review and Meta-Analyses.
Asmita Garg, Uttara Das, Neetu Shukla et al.
✦ AI-curated · Sources linked
In 30 seconds
This systematic review and meta-analysis examined blood and serum heavy-metal levels across dementia severity, drawing on six studies with 598 patients and 622 controls. Overall, levels were higher in patients than controls (SMD = 0.499, p = 0.000). Stage-specific analyses found no significant difference in mild dementia, but higher levels in moderate-to-severe dementia (SMD = 0.617, p = 0.000), driven mainly by cadmium and copper. The authors interpret the findings as consistent with metals accelerating progression rather than initiating dementia, while noting heterogeneity across studies.
Key findings
- Across dementia stages, patients had higher blood or serum heavy-metal levels than controls (SMD = 0.499, p = 0.000).
- No significant difference was found in mild dementia; moderate-to-severe dementia showed higher levels (SMD = 0.617, p = 0.000).
- In moderate-to-severe dementia, cadmium (SMD = 0.838, p = 0.019) and copper (SMD = 2.202, p = 0.001) were the main contributors.
Why it matters
The stage-specific pattern raises the possibility that environmental metal exposure is more closely associated with advanced dementia than with mild disease. This distinction may help frame research into progression and environmental risk assessment. However, pooled associations from a small, heterogeneous evidence base do not establish that metals cause worsening dementia or that reducing exposure changes clinical outcomes.
What to keep in mind
The meta-analysis included only six studies and reported heterogeneity; the evidence is observational and cannot establish that metal exposure accelerates dementia.